120 related articles for article (PubMed ID: 8387371)
1. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor.
Tsakona CP; Khwaja A; Goldstone AH
Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371
[No Abstract] [Full Text] [Related]
2. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.
De Witte T; Gratwohl A; Van der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
Bone Marrow Transplant; 1991; 7 Suppl 2():83. PubMed ID: 1908729
[No Abstract] [Full Text] [Related]
3. RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
Gorin NC; Coiffier B; Hayat M; Philip T; Vernant JP; Hervé P; Colombat P; Boivin P; Slavin S; Eugène-Jolchine I
Bone Marrow Transplant; 1991; 7 Suppl 2():82. PubMed ID: 1878733
[No Abstract] [Full Text] [Related]
4. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
Vadhan-Raj S; Broxmeyer HE; Hittelman WN
Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
[No Abstract] [Full Text] [Related]
5. The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.
Visani G; Gamberi B; Greenberg P; Advani R; Gulati S; Champlin R; Hoglund M; Karanes C; Williams S; Keating A
Bone Marrow Transplant; 1991; 7 Suppl 2():81. PubMed ID: 1878732
[No Abstract] [Full Text] [Related]
6. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
7. Patterns of primary degranulation as indicated by the mean myeloperoxidase index (MPXI) during bacteraemia in lymphoma transplants treated with growth factors.
Tsakona CP; Goldstone AH
Clin Lab Haematol; 1992; 14(4):273-80. PubMed ID: 1282446
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia.
Locatelli F; Pedrazzoli P; Zecca M; Maccario R; Giorgiani G; Prete L; Nespoli L; Severi F
Haematologica; 1991; 76(3):238-9. PubMed ID: 1743595
[TBL] [Abstract][Full Text] [Related]
9. Colony-stimulating factors in cancer therapy.
Morstyn G; Sheridan WP
Cancer Chemother Biol Response Modif; 1992; 13():308-26. PubMed ID: 1382528
[No Abstract] [Full Text] [Related]
10. The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
Rosenfeld CS; Nemunaitis J
Semin Hematol; 1992 Oct; 29(4 Suppl 3):19-26. PubMed ID: 1362822
[No Abstract] [Full Text] [Related]
11. Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application.
Neumanaitis J
Transfusion; 1993 Jan; 33(1):70-83. PubMed ID: 8424270
[No Abstract] [Full Text] [Related]
12. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution.
Calderwood S; Doyle JJ; Hitzler JK; Saunders EF; Freedman MH
Bone Marrow Transplant; 1996 Jul; 18(1):87-91. PubMed ID: 8832000
[TBL] [Abstract][Full Text] [Related]
13. [Rapid recovery after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) for neutropenia caused by indomethacin].
Costa RM; Leite J
Sangre (Barc); 1993 Dec; 38(6):502-3. PubMed ID: 8171389
[No Abstract] [Full Text] [Related]
14. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
Borota R; Borota J; Belić A; Gebauer E; Stefanović N
Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
[TBL] [Abstract][Full Text] [Related]
15. The impact of myeloid growth factors on engraftment following autologous bone marrow transplantation for malignant lymphoma.
Rabinowe SN; Nemunaitis J; Armitage J; Nadler LM
Semin Hematol; 1991 Apr; 28(2 Suppl 2):6-16. PubMed ID: 1712125
[No Abstract] [Full Text] [Related]
16. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma.
Fay JW; Bernstein SH
Semin Oncol; 1996 Apr; 23(2 Suppl 4):22-7. PubMed ID: 8600545
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
19. Marketing of recombinant granulocyte-macrophage colony-stimulating factor approved by FDA.
Clin Pharm; 1991 Jun; 10(6):411. PubMed ID: 2065520
[No Abstract] [Full Text] [Related]
20. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
